Global High-Throughput Screening Market

High-Throughput Screening Comprehensive Study by Type (Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, Services), Application (Chemical Biology Programs, Cell- & Organ-Based Screening, Biochemical Screening, Biological Active Compound Screening, Genomics, Proteomics, Compound Profiling), Technology (Cell-Based Assays, Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, Label-Free Technology), Detection Method (Mass Spectrometry (MS), Chromatography, Calorimetry, X-Ray Diffraction, Other Detection Methods) Players and Region - Global Market Outlook to 2030

High-Throughput Screening Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled

Report Objectives / Segmentation Covered

By Type
  • Reagents & Assay Kits
  • Instruments
  • Consumables & Accessories
  • Software
  • Services
By Application
  • Chemical Biology Programs
  • Cell- & Organ-Based Screening
  • Biochemical Screening
  • Biological Active Compound Screening
  • Genomics
  • Proteomics
  • Compound Profiling
By Technology
  • Cell-Based Assays
  • Lab-On-A-Chip
  • Ultra-High-Throughput Screening
  • Bioinformatics
  • Label-Free Technology

By Detection Method
  • Mass Spectrometry (MS)
  • Chromatography
  • Calorimetry
  • X-Ray Diffraction
  • Other Detection Methods

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Skilled Operators
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global High-Throughput Screening, by Type, Application, Technology, Detection Method and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global High-Throughput Screening (Value)
      • 5.2.1. Global High-Throughput Screening by: Type (Value)
        • 5.2.1.1. Reagents & Assay Kits
        • 5.2.1.2. Instruments
        • 5.2.1.3. Consumables & Accessories
        • 5.2.1.4. Software
        • 5.2.1.5. Services
      • 5.2.2. Global High-Throughput Screening by: Application (Value)
        • 5.2.2.1. Chemical Biology Programs
        • 5.2.2.2. Cell- & Organ-Based Screening
        • 5.2.2.3. Biochemical Screening
        • 5.2.2.4. Biological Active Compound Screening
        • 5.2.2.5. Genomics
        • 5.2.2.6. Proteomics
        • 5.2.2.7. Compound Profiling
      • 5.2.3. Global High-Throughput Screening by: Technology (Value)
        • 5.2.3.1. Cell-Based Assays
        • 5.2.3.2. Lab-On-A-Chip
        • 5.2.3.3. Ultra-High-Throughput Screening
        • 5.2.3.4. Bioinformatics
        • 5.2.3.5. Label-Free Technology
      • 5.2.4. Global High-Throughput Screening by: Detection Method (Value)
        • 5.2.4.1. Mass Spectrometry (MS)
        • 5.2.4.2. Chromatography
        • 5.2.4.3. Calorimetry
        • 5.2.4.4. X-Ray Diffraction
        • 5.2.4.5. Other Detection Methods
      • 5.2.5. Global High-Throughput Screening Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. High-Throughput Screening: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Agilent (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Danaher (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher Scientific (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. PerkinElmer (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Tecan Group (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Axxam (Italy)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merck Group (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bio-Rad (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hamilton Company (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Corning Incorporated (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. BioTek Instruments (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Aurora Biomed (Canada)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global High-Throughput Screening Sale, by Type, Application, Technology, Detection Method and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global High-Throughput Screening (Value)
      • 7.2.1. Global High-Throughput Screening by: Type (Value)
        • 7.2.1.1. Reagents & Assay Kits
        • 7.2.1.2. Instruments
        • 7.2.1.3. Consumables & Accessories
        • 7.2.1.4. Software
        • 7.2.1.5. Services
      • 7.2.2. Global High-Throughput Screening by: Application (Value)
        • 7.2.2.1. Chemical Biology Programs
        • 7.2.2.2. Cell- & Organ-Based Screening
        • 7.2.2.3. Biochemical Screening
        • 7.2.2.4. Biological Active Compound Screening
        • 7.2.2.5. Genomics
        • 7.2.2.6. Proteomics
        • 7.2.2.7. Compound Profiling
      • 7.2.3. Global High-Throughput Screening by: Technology (Value)
        • 7.2.3.1. Cell-Based Assays
        • 7.2.3.2. Lab-On-A-Chip
        • 7.2.3.3. Ultra-High-Throughput Screening
        • 7.2.3.4. Bioinformatics
        • 7.2.3.5. Label-Free Technology
      • 7.2.4. Global High-Throughput Screening by: Detection Method (Value)
        • 7.2.4.1. Mass Spectrometry (MS)
        • 7.2.4.2. Chromatography
        • 7.2.4.3. Calorimetry
        • 7.2.4.4. X-Ray Diffraction
        • 7.2.4.5. Other Detection Methods
      • 7.2.5. Global High-Throughput Screening Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. High-Throughput Screening: by Type(USD Million)
  • Table 2. High-Throughput Screening Reagents & Assay Kits , by Region USD Million (2018-2023)
  • Table 3. High-Throughput Screening Instruments , by Region USD Million (2018-2023)
  • Table 4. High-Throughput Screening Consumables & Accessories , by Region USD Million (2018-2023)
  • Table 5. High-Throughput Screening Software , by Region USD Million (2018-2023)
  • Table 6. High-Throughput Screening Services , by Region USD Million (2018-2023)
  • Table 7. High-Throughput Screening: by Application(USD Million)
  • Table 8. High-Throughput Screening Chemical Biology Programs , by Region USD Million (2018-2023)
  • Table 9. High-Throughput Screening Cell- & Organ-Based Screening , by Region USD Million (2018-2023)
  • Table 10. High-Throughput Screening Biochemical Screening , by Region USD Million (2018-2023)
  • Table 11. High-Throughput Screening Biological Active Compound Screening , by Region USD Million (2018-2023)
  • Table 12. High-Throughput Screening Genomics , by Region USD Million (2018-2023)
  • Table 13. High-Throughput Screening Proteomics , by Region USD Million (2018-2023)
  • Table 14. High-Throughput Screening Compound Profiling , by Region USD Million (2018-2023)
  • Table 15. High-Throughput Screening: by Technology(USD Million)
  • Table 16. High-Throughput Screening Cell-Based Assays , by Region USD Million (2018-2023)
  • Table 17. High-Throughput Screening Lab-On-A-Chip , by Region USD Million (2018-2023)
  • Table 18. High-Throughput Screening Ultra-High-Throughput Screening , by Region USD Million (2018-2023)
  • Table 19. High-Throughput Screening Bioinformatics , by Region USD Million (2018-2023)
  • Table 20. High-Throughput Screening Label-Free Technology , by Region USD Million (2018-2023)
  • Table 21. High-Throughput Screening: by Detection Method(USD Million)
  • Table 22. High-Throughput Screening Mass Spectrometry (MS) , by Region USD Million (2018-2023)
  • Table 23. High-Throughput Screening Chromatography , by Region USD Million (2018-2023)
  • Table 24. High-Throughput Screening Calorimetry , by Region USD Million (2018-2023)
  • Table 25. High-Throughput Screening X-Ray Diffraction , by Region USD Million (2018-2023)
  • Table 26. High-Throughput Screening Other Detection Methods , by Region USD Million (2018-2023)
  • Table 27. South America High-Throughput Screening, by Country USD Million (2018-2023)
  • Table 28. South America High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 29. South America High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 30. South America High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 31. South America High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 32. Brazil High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 33. Brazil High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 34. Brazil High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 35. Brazil High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 36. Argentina High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 37. Argentina High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 38. Argentina High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 39. Argentina High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 40. Rest of South America High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 41. Rest of South America High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 42. Rest of South America High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 43. Rest of South America High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 44. Asia Pacific High-Throughput Screening, by Country USD Million (2018-2023)
  • Table 45. Asia Pacific High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 46. Asia Pacific High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 47. Asia Pacific High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 48. Asia Pacific High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 49. China High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 50. China High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 51. China High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 52. China High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 53. Japan High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 54. Japan High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 55. Japan High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 56. Japan High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 57. India High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 58. India High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 59. India High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 60. India High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 61. South Korea High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 62. South Korea High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 63. South Korea High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 64. South Korea High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 65. Taiwan High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 66. Taiwan High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 67. Taiwan High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 68. Taiwan High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 69. Australia High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 70. Australia High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 71. Australia High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 72. Australia High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 73. Rest of Asia-Pacific High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 74. Rest of Asia-Pacific High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 75. Rest of Asia-Pacific High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 76. Rest of Asia-Pacific High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 77. Europe High-Throughput Screening, by Country USD Million (2018-2023)
  • Table 78. Europe High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 79. Europe High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 80. Europe High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 81. Europe High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 82. Germany High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 83. Germany High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 84. Germany High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 85. Germany High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 86. France High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 87. France High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 88. France High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 89. France High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 90. Italy High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 91. Italy High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 92. Italy High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 93. Italy High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 94. United Kingdom High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 95. United Kingdom High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 96. United Kingdom High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 97. United Kingdom High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 98. Netherlands High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 99. Netherlands High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 100. Netherlands High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 101. Netherlands High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 102. Rest of Europe High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 103. Rest of Europe High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 104. Rest of Europe High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 105. Rest of Europe High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 106. MEA High-Throughput Screening, by Country USD Million (2018-2023)
  • Table 107. MEA High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 108. MEA High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 109. MEA High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 110. MEA High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 111. Middle East High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 112. Middle East High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 113. Middle East High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 114. Middle East High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 115. Africa High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 116. Africa High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 117. Africa High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 118. Africa High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 119. North America High-Throughput Screening, by Country USD Million (2018-2023)
  • Table 120. North America High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 121. North America High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 122. North America High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 123. North America High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 124. United States High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 125. United States High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 126. United States High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 127. United States High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 128. Canada High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 129. Canada High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 130. Canada High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 131. Canada High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 132. Mexico High-Throughput Screening, by Type USD Million (2018-2023)
  • Table 133. Mexico High-Throughput Screening, by Application USD Million (2018-2023)
  • Table 134. Mexico High-Throughput Screening, by Technology USD Million (2018-2023)
  • Table 135. Mexico High-Throughput Screening, by Detection Method USD Million (2018-2023)
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. High-Throughput Screening: by Type(USD Million)
  • Table 149. High-Throughput Screening Reagents & Assay Kits , by Region USD Million (2025-2030)
  • Table 150. High-Throughput Screening Instruments , by Region USD Million (2025-2030)
  • Table 151. High-Throughput Screening Consumables & Accessories , by Region USD Million (2025-2030)
  • Table 152. High-Throughput Screening Software , by Region USD Million (2025-2030)
  • Table 153. High-Throughput Screening Services , by Region USD Million (2025-2030)
  • Table 154. High-Throughput Screening: by Application(USD Million)
  • Table 155. High-Throughput Screening Chemical Biology Programs , by Region USD Million (2025-2030)
  • Table 156. High-Throughput Screening Cell- & Organ-Based Screening , by Region USD Million (2025-2030)
  • Table 157. High-Throughput Screening Biochemical Screening , by Region USD Million (2025-2030)
  • Table 158. High-Throughput Screening Biological Active Compound Screening , by Region USD Million (2025-2030)
  • Table 159. High-Throughput Screening Genomics , by Region USD Million (2025-2030)
  • Table 160. High-Throughput Screening Proteomics , by Region USD Million (2025-2030)
  • Table 161. High-Throughput Screening Compound Profiling , by Region USD Million (2025-2030)
  • Table 162. High-Throughput Screening: by Technology(USD Million)
  • Table 163. High-Throughput Screening Cell-Based Assays , by Region USD Million (2025-2030)
  • Table 164. High-Throughput Screening Lab-On-A-Chip , by Region USD Million (2025-2030)
  • Table 165. High-Throughput Screening Ultra-High-Throughput Screening , by Region USD Million (2025-2030)
  • Table 166. High-Throughput Screening Bioinformatics , by Region USD Million (2025-2030)
  • Table 167. High-Throughput Screening Label-Free Technology , by Region USD Million (2025-2030)
  • Table 168. High-Throughput Screening: by Detection Method(USD Million)
  • Table 169. High-Throughput Screening Mass Spectrometry (MS) , by Region USD Million (2025-2030)
  • Table 170. High-Throughput Screening Chromatography , by Region USD Million (2025-2030)
  • Table 171. High-Throughput Screening Calorimetry , by Region USD Million (2025-2030)
  • Table 172. High-Throughput Screening X-Ray Diffraction , by Region USD Million (2025-2030)
  • Table 173. High-Throughput Screening Other Detection Methods , by Region USD Million (2025-2030)
  • Table 174. South America High-Throughput Screening, by Country USD Million (2025-2030)
  • Table 175. South America High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 176. South America High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 177. South America High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 178. South America High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 179. Brazil High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 180. Brazil High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 181. Brazil High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 182. Brazil High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 183. Argentina High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 184. Argentina High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 185. Argentina High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 186. Argentina High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 187. Rest of South America High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 188. Rest of South America High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 189. Rest of South America High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 190. Rest of South America High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 191. Asia Pacific High-Throughput Screening, by Country USD Million (2025-2030)
  • Table 192. Asia Pacific High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 193. Asia Pacific High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 194. Asia Pacific High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 195. Asia Pacific High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 196. China High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 197. China High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 198. China High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 199. China High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 200. Japan High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 201. Japan High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 202. Japan High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 203. Japan High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 204. India High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 205. India High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 206. India High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 207. India High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 208. South Korea High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 209. South Korea High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 210. South Korea High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 211. South Korea High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 212. Taiwan High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 213. Taiwan High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 214. Taiwan High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 215. Taiwan High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 216. Australia High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 217. Australia High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 218. Australia High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 219. Australia High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 220. Rest of Asia-Pacific High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 221. Rest of Asia-Pacific High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 222. Rest of Asia-Pacific High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 223. Rest of Asia-Pacific High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 224. Europe High-Throughput Screening, by Country USD Million (2025-2030)
  • Table 225. Europe High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 226. Europe High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 227. Europe High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 228. Europe High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 229. Germany High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 230. Germany High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 231. Germany High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 232. Germany High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 233. France High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 234. France High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 235. France High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 236. France High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 237. Italy High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 238. Italy High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 239. Italy High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 240. Italy High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 241. United Kingdom High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 242. United Kingdom High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 243. United Kingdom High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 244. United Kingdom High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 245. Netherlands High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 246. Netherlands High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 247. Netherlands High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 248. Netherlands High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 249. Rest of Europe High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 250. Rest of Europe High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 251. Rest of Europe High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 252. Rest of Europe High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 253. MEA High-Throughput Screening, by Country USD Million (2025-2030)
  • Table 254. MEA High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 255. MEA High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 256. MEA High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 257. MEA High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 258. Middle East High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 259. Middle East High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 260. Middle East High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 261. Middle East High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 262. Africa High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 263. Africa High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 264. Africa High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 265. Africa High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 266. North America High-Throughput Screening, by Country USD Million (2025-2030)
  • Table 267. North America High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 268. North America High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 269. North America High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 270. North America High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 271. United States High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 272. United States High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 273. United States High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 274. United States High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 275. Canada High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 276. Canada High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 277. Canada High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 278. Canada High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 279. Mexico High-Throughput Screening, by Type USD Million (2025-2030)
  • Table 280. Mexico High-Throughput Screening, by Application USD Million (2025-2030)
  • Table 281. Mexico High-Throughput Screening, by Technology USD Million (2025-2030)
  • Table 282. Mexico High-Throughput Screening, by Detection Method USD Million (2025-2030)
  • Table 283. Research Programs/Design for This Report
  • Table 284. Key Data Information from Secondary Sources
  • Table 285. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global High-Throughput Screening: by Type USD Million (2018-2023)
  • Figure 5. Global High-Throughput Screening: by Application USD Million (2018-2023)
  • Figure 6. Global High-Throughput Screening: by Technology USD Million (2018-2023)
  • Figure 7. Global High-Throughput Screening: by Detection Method USD Million (2018-2023)
  • Figure 8. South America High-Throughput Screening Share (%), by Country
  • Figure 9. Asia Pacific High-Throughput Screening Share (%), by Country
  • Figure 10. Europe High-Throughput Screening Share (%), by Country
  • Figure 11. MEA High-Throughput Screening Share (%), by Country
  • Figure 12. North America High-Throughput Screening Share (%), by Country
  • Figure 13. Global High-Throughput Screening share by Players 2023 (%)
  • Figure 14. Global High-Throughput Screening share by Players (Top 3) 2023(%)
  • Figure 15. Global High-Throughput Screening share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Agilent (United States) Revenue, Net Income and Gross profit
  • Figure 18. Agilent (United States) Revenue: by Geography 2023
  • Figure 19. Danaher (United States) Revenue, Net Income and Gross profit
  • Figure 20. Danaher (United States) Revenue: by Geography 2023
  • Figure 21. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 22. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 23. PerkinElmer (United States) Revenue, Net Income and Gross profit
  • Figure 24. PerkinElmer (United States) Revenue: by Geography 2023
  • Figure 25. Tecan Group (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. Tecan Group (Switzerland) Revenue: by Geography 2023
  • Figure 27. Axxam (Italy) Revenue, Net Income and Gross profit
  • Figure 28. Axxam (Italy) Revenue: by Geography 2023
  • Figure 29. Merck Group (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Merck Group (Germany) Revenue: by Geography 2023
  • Figure 31. Bio-Rad (United States) Revenue, Net Income and Gross profit
  • Figure 32. Bio-Rad (United States) Revenue: by Geography 2023
  • Figure 33. Hamilton Company (United States) Revenue, Net Income and Gross profit
  • Figure 34. Hamilton Company (United States) Revenue: by Geography 2023
  • Figure 35. Corning Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 36. Corning Incorporated (United States) Revenue: by Geography 2023
  • Figure 37. BioTek Instruments (United States) Revenue, Net Income and Gross profit
  • Figure 38. BioTek Instruments (United States) Revenue: by Geography 2023
  • Figure 39. Aurora Biomed (Canada) Revenue, Net Income and Gross profit
  • Figure 40. Aurora Biomed (Canada) Revenue: by Geography 2023
  • Figure 41. Global High-Throughput Screening: by Type USD Million (2025-2030)
  • Figure 42. Global High-Throughput Screening: by Application USD Million (2025-2030)
  • Figure 43. Global High-Throughput Screening: by Technology USD Million (2025-2030)
  • Figure 44. Global High-Throughput Screening: by Detection Method USD Million (2025-2030)
  • Figure 45. South America High-Throughput Screening Share (%), by Country
  • Figure 46. Asia Pacific High-Throughput Screening Share (%), by Country
  • Figure 47. Europe High-Throughput Screening Share (%), by Country
  • Figure 48. MEA High-Throughput Screening Share (%), by Country
  • Figure 49. North America High-Throughput Screening Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Agilent (United States)
  • Danaher (United States)
  • Thermo Fisher Scientific (United States)
  • PerkinElmer (United States)
  • Tecan Group (Switzerland)
  • Axxam (Italy)
  • Merck Group (Germany)
  • Bio-Rad (United States)
  • Hamilton Company (United States)
  • Corning Incorporated (United States)
  • BioTek Instruments (United States)
  • Aurora Biomed (Canada)
Select User Access Type

Key Highlights of Report


Mar 2024 221 Pages 84 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global High-Throughput Screening Market Quantitative research analysis
Global High-Throughput Screening Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global High-Throughput Screening Market Report?

Have a Query? Click Here

Other Related Reports

Hemorrhagic Shock Treatment Comprehensive Study by Causes (Severe Burns, Deep Cuts, Gunshot Wounds, Others), Diagnosis (X-rays, Blood tests, Ultrasound, CT scan, MRI), Symptoms (Abdominal Pain, Abdom...
$ 3500
NewBorn Screening Comprehensive Study by Type (Instruments {Newborn Disorder Screening Instruments, Newborn Hearing Screening Instruments (Hearing Screening Devices and Hearing Screening Accessories)...
$ 3750
Interventional Radiology Comprehensive Study by Type (X-ray, Computed Tomography, Magnetic Resonance Imaging (MRI), Ultrasound), Application (Oncology, Cardiology, Urology & Nephrology, Gastroenterol...
$ 3750
Wireless Health and Fitness Devices Comprehensive Study by Type (Wrist Strap Type Devices, Wearable Type Devices, Other), Application (Monitoring, Diagnosis), Sales Channel (Pharmacies, Online Channe...
$ 3750
Urinalysis Analyzers Comprehensive Study by Type (Semi-Automatic, Fully-Automatic), Application (Urinary Tract Infections, Kidney Diseases, Diabetes, Others), Sales (Online, Offline), End-User (Hospi...
$ 3350
Dental Imaging Comprehensive Study by Type (Extraoral Imaging, Intraoral Imaging, Others), Application (Diagnostic Applications, Therapeutic Applications, Cosmetic Applications, Forensic Applications...
$ 3500